Mutant p53 Protein as a Predictor of Survival in Endometrial Carcinoma

Author： Strang P. Nordstrom B. Nilsson S. Bergstrom R. Tribukait B.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.32, Iss.4, 1996-04, pp. : 598-602

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P53 Expression in Adenomyosis in Endometrial Carcinoma Patients

By Taskin M. Lallas T.A. Shevchuk M. Barber H.R.K.

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 241-246

Academic Press

Access to resources Recommend Favorite

p53 Interference and Growth Inhibition in p53-Mutant and Overexpressing Endometrial Cancer Cell Lines

By Janicek M.F. Angioli R. Unal A.D. Sevin B.-U. Madrigal M. Estape R. Averette H.E.

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 94-102

Elsevier

Access to resources Recommend Favorite

p53 Expression as a Prognostic Indicator of 5-Year Survival in Endometrial Cancer

By Geisler J.P. Geisler H.E. Wiemann M.C. Zhou Z. Miller G.A. Crabtree W.

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 468-471

Elsevier

Access to resources Recommend Favorite

Endometrial Carcinoma Associated with Hyperplasia- Immunohistochemical Study of Angiogenesis and p53 Expression

By Kaku T. Kamura T. Hirakawa T. Sakai K. Amada S. Kobayashi H. Nakano H.

Gynecologic Oncology, Vol. 72, Iss. 1, 1999-01 ,pp. : 51-55

Elsevier

Access to resources Recommend Favorite

Dominant-Negative Mutation of p53 Tumor Suppressor Gene in Endometrial Carcinoma

By Sakuragi N. Hirai A. Tada M. Yamada H. Yamamoto R. Fujimoto S. Moriuchi T.

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 485-490

Elsevier

Access to resources Recommend Favorite